Skip to main content
. 2022 Mar 23;12:799678. doi: 10.3389/fcimb.2022.799678

Table 8.

Benchmarking of diagnostics for SARS-CoV-2 based on non-isothermal amplification methods issued with EUA, or CE mark.

Tests Producing company Validation Type of sample processing Ready for Pooling Amplification method Detection strategy Detection platform Duration (min) Detection limit (copies/µL) Specimen under analysis Targets, Multiplex, or Multi-species
Cobas SARS-CoV-2 Roche Molecular Systems, Inc EUA, CE-IVD Automated full extraction Yes RT-qPCR Fluorescence, Taqman probes Fully automated equipment <210 0.046 Self-collected – URT swab (NS)//Collected by healthcare worker – URT swabs (NS,NP,OP) Multi-target, ORF1ab and E and Multiplex
NeuMoDx SARS-CoV-2 assay NeuMoDx Molecular, Inc EUA, CE-IVD Automated full extraction No RT-qPCR Fluorescence, Taqman probes Fully automated equipment _ 0.050 (saliva) or 0.150 (NP) Supervised self-collection – saliva collected with NeuMoDx Saliva Collection Kit//Collected by healthcare worker - URT swabs (NS, NP, OP) and BAL Multi-target, ORF1ab (NSP2) and N and Multiplex
Xpert Omni SARS-CoV-2 Assay Cepheid EUA, CE-IVD Automated full extraction No RT-qPCR Fluorescence, Nos-specified oligonucleotide hydrolysis probes Fully automated equipment _ 0.4 Collected by healthcare worker – URT swabs (NS,NP,OP, mid-turbinate) and NS wash, or aspirate Multi-target, N and E and Multiplex
Bio-Rad Reliance SARS-CoV-2 RT-PCR Assay kit Bio-Rad Laboratories, Inc EUA Manual, or Automated full extraction No RT-qPCR Fluorescence, No-specified oligonucleotide probes qPCR equipment _ 0.125-0.250 Collected by healthcare worker – URT swabs (NS,NP, OP, mid-turbinate), nasal aspirates and nasal washes Multi-target, two N gene regions and Multiplex
BioFire COVID-19 Test BioFire Diagnostics,LLC EUA Automated full extraction Yes N-RT-qPCR End-point Melting Curve data qPCR equipment 50 5.4 Collected by healthcare worker – URT swabs (NS,OP, mid-turbinate), LRT samples (sputum, tracheal aspirates and BAL) Multi-target, two ORF1ab regions and ORF8, Multiplex
Lyra SARS-CoV-2 Assay Quidel, Inc EUA, CE-IVD Automated full extraction No RT-qPCR Fluorescence, Taqman probes qPCR equipment 135 6 Collected by healthcare worker – URT swabs (NP,OP) Single-target, ORF1ab
Quest SARS-CoV-2 rRT-PCR Quest Diagnostics Infectious Disease, Inc EUA Automated full extraction Yes RT-qPCR Fluorescence, Taqman probes qPCR equipment _ 0.136 Self-collected – URT swab (NS)//Collected by healthcare worker – URT (NP,OP) swabs and LRT samples (sputum, tracheal aspirates and BAL) Multi-target, two N gene regions and Multiplex
Quest SARS-CoV-2 rRT-PCR BioFire Diagnostics, LLC EUA Automated full extraction No N-RT-qPCR End-point Melting Curve data Fully automatedequipment 50 0.5 (SARS-CoV-2), in the range 0.01 to 3 for other pathogens Collected by healthcare worker - URT swab (NP) Multi-target, S and M (for SARS-CoV-2),Multiplex and Multi-species,
Quest SARS-CoV-2 rRT-PCR Bio-Rad Laboratories, Inc EUA Manual or Automated full extraction No RT-ddPCR Fluorescence, Taqman probes Digital PCR equipment <500 0.4 Collected by healthcare worker - URT swabs (NS, NP, OP, mid-turbinate), aspirates (NS,NP) and BAL Multi-target, two N gene regions and Multiplex
LumiraDx SARS-CoV-2 RNA STAR Complete Lumira Dx UK Ltd EUA, CE-IVD Brief lysis step No qSTAR Fluorescence, Molecular beacons qPCR equipment <20 1.875 Collected by healthcare worker - URT swabs (NS, NP, OP, mid-turbinate) and BAL Single-target, ORF1ab

All the information was retrieved from the instruction for use supplied in FDA website (https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2) and the data sheets attached to each test validated with CE-IVD, which are listed in European Comission website (https://covid-19-diagnostics.jrc.ec.europa.eu/devices?device_id=&manufacturer=&text_name=&marking=Yes&method=&rapid_diag=&target_type=&search_method=AND#form_content). Both sites were last accessed on 02.02.2022.